Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8483
Reference
MSAN(2025)30
Name
Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml prefilled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill® 100units/ml solution for injection 3ml cartridges are being discontinued; stock is anticipated to be exhausted by the end of 2026.
Clinical advice on the discontinuation of all Levemir® presentations is being produced and will follow in the coming months.
TO NOTE: This is the third of three MSANs covering discontinuations of Novo Nordisk insulin products (NovoRapid® FlexTouch®, Insulatard® Penfill® and all Levemir® presentations).
Contact Name
Contact Email
Contact Address
Created
2025-06-18 12:23:00
Click to go back to homepage